SCOTT HEILMANN: Open Payments
NPI 1164875894 · PANAMA CITY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,640 in 69 payments from 25 companies in 2025. Trend: 2023 $2,622 · 2024 $1,873 · 2025 $1,640
Food & beverage: $1,640
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $242 |
| Novo Nordisk Inc | 4 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $140 |
| GlaxoSmithKline, LLC. | 8 | $130 |
| Otsuka America Pharmaceutical, Inc. | 1 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $100 |
| ABBVIE INC. | 4 | $75 |
| PFIZER INC. | 4 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
Products named: AIRSUPRA, CAPLYTA, Ozempic, TRELEGY ELLIPTA, REXULTI, Kerendia, LEQVIO, XIFAXAN.
Industry payments across FL — which companies pay providers there.
